Daigo Wakana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daigo Wakana has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Hyuga
Division of Biological Chemistry & Biologicals, National Institute of Health Sciences, 3–25–26 Tonomachi, Kawasaki-ku, Kawasaki 210–9501, Japan
1 shared publication - Morio Yoshimura
Department of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan
1 shared publication - Saori Yamakami
Department of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan
1 shared publication - Sumiko Hyuga
Laboratory of Kampo Clinical Research, Oriental Medicine Research Center, School of Pharmacy Kitasato University Tokyo Japan
1 shared publication - Takashi Yoshida
College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan
1 shared publication - Toshihiko Hanawa
Oriental Medicine Research Center of Kitasato University, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
Characterization of Phenolic Constituents from Ephedra Herb Extract
Nine known compounds: trans-cinnamic acid, catechin, syringin, epicatechin, symplocoside, kaempferol 3-O-rhamnoside 7-O-glucoside, isovitexin 2-O-rhamnoside, herbacetin 7-O-glucoside, and pollenitin B and a new flavonoid glycoside, characterized as herbacetin 7-O-neohesperidoside (1) on the basis of spectroscopic analysis and chemical evidence, were isolated from a traditional crude drug, “Ephedra herb extract”. Compound 1 had no effects on HGF-induced motility, whereas herbacetin, which is an aglycone of 1, significantly inhibited it.
Open AccessCharacterization of Phenolic Constituents from Ephedra Herb Extract
Nine known compounds: trans-cinnamic acid, catechin, syringin, epicatechin, symplocoside, kaempferol 3-O-rhamnoside 7-O-glucoside, isovitexin 2-O-rhamnoside, herbacetin 7-O-glucoside, and pollenitin B and a new flavonoid glycoside, characterized as herbacetin 7-O-neohesperidoside (1) on the basis of spectroscopic analysis and chemical evidence, were isolated from a traditional crude drug, “Ephedra herb extract”. Compound 1 had no effects on HGF-induced motility, whereas herbacetin, which is an aglycone of 1, significantly inhibited it.